Concepedia

Author

S. Hibbitts

University of Virginia Health System

Also Known As

S Hibbitts, S. Hibbitts, Sarah C. Hibbitts, Sarah Hibbitts

13

Publications

1.1K

Citations

9

H-Index

28

Concepts

All Affiliations

University of Virginia Health SystemUniversity of VirginiaCardiff University
SH

About

S. Hibbitts is an author at University of Virginia Health System specializing in medicine, vaccination, and tumor immunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

296

2

Immunology

2

2

254

3

Public Health

1

1

13

4

Allergy

1

1

229

5

Epidemiology

1

1

13

S. Hibbitts

×

9

Publications

1.1K

Citations

9

H-Index

YearCitations

Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

Craig L. Slingluff, Gina R. Petroni, Galina V. Yamshchikov,

Journal of Clinical Oncology

2003

321

Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.

Craig L. Slingluff, Galina V. Yamshchikov, Patrice Y. Neese,

PubMed

2001

229

Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting

Craig L. Slingluff, Gina R. Petroni, Kimberly A. Chianese‐Bullock,

Clinical Cancer Research

2007

160

Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed Schedule

Craig L. Slingluff, Gina R. Petroni, Galina V. Yamshchikov,

Journal of Clinical Oncology

2004

146

MAGE-A1-, MAGE-A10-, and gp100-Derived Peptides Are Immunogenic When Combined with Granulocyte-Macrophage Colony-Stimulating Factor and Montanide ISA-51 Adjuvant and Administered as Part of a Multipeptide Vaccine for Melanoma

Kimberly A. Chianese‐Bullock, Jennifer Pressley, Courtney F. Garbee,

The Journal of Immunology

2005

124

Comparison of the PapilloCheck® DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set

J. Jones, Ned Powell, Amanda Tristram,

Journal of Clinical Virology

2009

29

Evaluation of the Sentinel Immunized Node for Immune Monitoring of Cancer Vaccines

Craig L. Slingluff, Galina V. Yamshchikov, Kevin T. Hogan,

Annals of Surgical Oncology

2008

25

Competition Among Peptides in Melanoma Vaccines for Binding to MHC Molecules

Lee W. Thompson, Courtney F. Garbee, S. Hibbitts,

Journal of Immunotherapy

2004

14

Should boys receive the human papillomavirus vaccine? Yes

S. Hibbitts

BMJ

2009

13

Page 1